Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | journal | 141427 | 7% | 6% | 273 |
| 2 | NEWCASTLE DISEASE VIRUS | authKW | 67376 | 2% | 11% | 76 |
| 3 | ANTITUMOR RESISTANCE | authKW | 45879 | 0% | 78% | 7 |
| 4 | ACTIVE SPECIFIC IMMUNOTHERAPY | authKW | 40683 | 0% | 30% | 16 |
| 5 | EKSPERIMENTALNAYA ONKOLOGIYA | journal | 38212 | 2% | 6% | 75 |
| 6 | ADOPTIVE IMMUNOTHERAPY | authKW | 36799 | 1% | 8% | 54 |
| 7 | ONCOLOGY | WoSSC | 31573 | 48% | 0% | 1787 |
| 8 | VIRAL ONCOLYSATE | authKW | 26966 | 0% | 80% | 4 |
| 9 | AF2240 | authKW | 25282 | 0% | 100% | 3 |
| 10 | MTH 68 H | authKW | 25282 | 0% | 100% | 3 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 31573 | 48% | 0% | 1787 |
| 2 | Immunology | 18546 | 34% | 0% | 1275 |
| 3 | Medicine, Research & Experimental | 1470 | 9% | 0% | 319 |
| 4 | Transplantation | 219 | 2% | 0% | 74 |
| 5 | Surgery | 206 | 6% | 0% | 236 |
| 6 | Pharmacology & Pharmacy | 189 | 7% | 0% | 257 |
| 7 | CYTOLOGY & HISTOLOGY | 138 | 0% | 0% | 12 |
| 8 | Cell Biology | 85 | 5% | 0% | 174 |
| 9 | Allergy | 78 | 1% | 0% | 33 |
| 10 | Virology | 60 | 1% | 0% | 56 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CELLULAR IMMUNOL | 23873 | 1% | 5% | 54 |
| 2 | RE KAVETSKY EXPT PATHOL ONCOL RADIOBIOL | 21316 | 1% | 12% | 22 |
| 3 | SURG FF50 | 19259 | 0% | 57% | 4 |
| 4 | CELLULAR IMMUNOL D010 | 18960 | 0% | 75% | 3 |
| 5 | ABT 0710 | 16855 | 0% | 100% | 2 |
| 6 | ABT ZELLULARE IMMUNOL G0100 | 16855 | 0% | 100% | 2 |
| 7 | BIOPHARMACEUT TEACHING | 16855 | 0% | 100% | 2 |
| 8 | MOL TUMOR IMMUNOL | 13370 | 0% | 18% | 9 |
| 9 | ABT ZELLULARE IMMUNOL | 11235 | 0% | 67% | 2 |
| 10 | SURG FF5 | 11235 | 0% | 67% | 2 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 141427 | 7% | 6% | 273 |
| 2 | EKSPERIMENTALNAYA ONKOLOGIYA | 38212 | 2% | 6% | 75 |
| 3 | CANCER RESEARCH | 17617 | 8% | 1% | 289 |
| 4 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 14387 | 2% | 3% | 59 |
| 5 | EXPERIMENTAL ONCOLOGY | 14203 | 1% | 5% | 32 |
| 6 | JOURNAL OF THE NATIONAL CANCER INSTITUTE | 9861 | 2% | 2% | 73 |
| 7 | INTERNATIONAL JOURNAL OF CANCER | 7306 | 4% | 1% | 135 |
| 8 | CELLULAR IMMUNOLOGY | 7265 | 2% | 1% | 83 |
| 9 | JOURNAL OF IMMUNOTHERAPY | 6694 | 1% | 2% | 37 |
| 10 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 6210 | 1% | 4% | 19 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |